| 1 |
-
Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes
-
3/6/2026 8:56:27 AM | Browse: 32 | Download: 139
|
| 2 |
-
Dynamic immune response and influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study
-
2/12/2026 11:20:22 AM | Browse: 46 | Download: 228
|
| 3 |
-
Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease
-
1/27/2026 10:12:32 AM | Browse: 39 | Download: 159
|
| 4 |
-
Transcriptome profiles of peripheral blood mononuclear cells differentiate male adolescents with non-alcoholic fatty liver disease from healthy peers
-
12/26/2025 10:27:29 AM | Browse: 55 | Download: 203
|
| 5 |
-
Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease
-
12/22/2025 7:43:01 AM | Browse: 56 | Download: 175
|
| 6 |
-
Clinical characteristics of colorectal polyps in patients with non-alcoholic fatty liver disease in high altitude areas
-
12/11/2025 8:21:00 AM | Browse: 66 | Download: 224
|
| 7 |
-
Influence of an internet-based proactive follow-up management model on the prognosis of nonalcoholic fatty liver disease
-
11/28/2025 3:10:39 AM | Browse: 66 | Download: 344
|
| 8 |
-
Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes
-
11/27/2025 7:54:00 AM | Browse: 68 | Download: 205
|
| 9 |
-
Lysosomal acid lipase deficiency: The forgotten link between liver and cardiovascular disease
-
11/21/2025 5:52:41 AM | Browse: 101 | Download: 219
|
| 10 |
-
Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease
-
10/27/2025 10:57:53 AM | Browse: 197 | Download: 341
|
| 11 |
-
Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications
-
10/24/2025 7:36:33 AM | Browse: 188 | Download: 232
|
| 12 |
-
Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy
-
9/24/2025 9:01:56 AM | Browse: 144 | Download: 359
|
| 13 |
-
Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia
-
9/18/2025 9:55:58 AM | Browse: 473 | Download: 416
|
| 14 |
-
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression
-
8/27/2025 9:21:11 AM | Browse: 229 | Download: 376
|
| 15 |
-
Myths and facts about the role of diet in metabolic dysfunctionassociated steatotic liver disease
-
8/27/2025 9:21:10 AM | Browse: 164 | Download: 557
|
| 16 |
-
Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment
-
8/27/2025 3:43:59 AM | Browse: 158 | Download: 356
|
| 17 |
-
TSC22D1 promotes liver sinusoidal endothelial cell dysfunction and induces macrophage M1 polarization in non-alcoholic fatty liver disease
-
8/18/2025 10:04:51 AM | Browse: 82 | Download: 301
|
| 18 |
-
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
-
7/25/2025 12:09:44 PM | Browse: 121 | Download: 382
|
| 19 |
-
MANPOWER study: Real-world post-hoc analysis assessing essential phospholipids for non-alcoholic fatty liver disease from the Russian registry
-
6/26/2025 7:27:55 AM | Browse: 116 | Download: 619
|
| 20 |
-
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
-
6/26/2025 7:27:54 AM | Browse: 178 | Download: 598
|
| 21 |
-
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis
-
6/20/2025 7:30:13 AM | Browse: 100 | Download: 383
|
| 22 |
-
Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease?
-
5/26/2025 9:15:10 AM | Browse: 132 | Download: 519
|
| 23 |
-
Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease
-
4/27/2025 3:54:33 AM | Browse: 147 | Download: 643
|
| 24 |
-
Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study
-
4/2/2025 10:54:11 AM | Browse: 177 | Download: 756
|
| 25 |
-
Association of cardiovascular health metrics and metabolic associated fatty liver disease: Methodological limitations, and future directions
-
3/26/2025 4:06:53 AM | Browse: 103 | Download: 370
|
| 26 |
-
Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
-
2/24/2025 5:39:17 AM | Browse: 150 | Download: 589
|
| 27 |
-
ILF3 inhibits p-AMPK expression to drive non-alcoholic fatty liver disease progression
-
2/20/2025 8:40:00 AM | Browse: 171 | Download: 767
|
| 28 |
-
Liver function linked to bone health: A bibliometric of the liver-bone axis
-
2/20/2025 8:39:56 AM | Browse: 187 | Download: 666
|
| 29 |
-
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
-
2/20/2025 8:39:45 AM | Browse: 133 | Download: 416
|
| 30 |
-
Roles of olive oil and physical exercise in non-alcoholic fatty liver disease after ultrasound-based evaluation
-
2/20/2025 8:39:33 AM | Browse: 94 | Download: 478
|
| 31 |
-
Association of non-alcoholic fatty liver disease with glycemic control among patients with type 2 diabetes mellitus at Limbe Regional Hospital, Southwest, Cameroon
-
2/20/2025 8:39:16 AM | Browse: 156 | Download: 757
|
| 32 |
-
Association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis: From an analysis of a population-based study
-
2/20/2025 8:38:48 AM | Browse: 37 | Download: 141
|
| 33 |
-
Oxidative stress-induced circSOD2 inhibits osteogenesis through sponging miR-29b in metabolic-associated fatty liver disease
-
2/18/2025 9:00:59 AM | Browse: 142 | Download: 923
|
| 34 |
-
Herbal medicine as a potential treatment for non-alcoholic fatty liver disease
-
2/18/2025 9:00:45 AM | Browse: 192 | Download: 567
|
| 35 |
-
Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease
-
2/14/2025 10:33:16 AM | Browse: 133 | Download: 583
|
| 36 |
-
Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway
-
1/10/2025 8:40:02 AM | Browse: 126 | Download: 668
|
| 37 |
-
Critical assessment of the reported bidirectional associations between gallstone, non-alcoholic fatty liver, and kidney stone diseases
-
12/30/2024 9:49:58 AM | Browse: 133 | Download: 706
|
| 38 |
-
Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders
-
12/30/2024 6:47:30 AM | Browse: 94 | Download: 481
|
| 39 |
-
Exploring the links between gallstone disease, non-alcoholic fatty liver disease, and kidney stones: A path to comprehensive prevention
-
12/30/2024 6:47:30 AM | Browse: 125 | Download: 403
|
| 40 |
-
Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
-
11/29/2024 2:50:17 PM | Browse: 227 | Download: 790
|
| 41 |
-
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease
-
11/26/2024 7:20:28 AM | Browse: 181 | Download: 615
|
| 42 |
-
Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease
-
11/21/2024 7:04:51 AM | Browse: 131 | Download: 687
|
| 43 |
-
Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease
-
11/21/2024 7:04:50 AM | Browse: 167 | Download: 564
|
| 44 |
-
Vitamin D 1,25-Dihydroxyvitamin D₃ reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization
-
11/12/2024 12:23:35 PM | Browse: 227 | Download: 857
|
| 45 |
-
Machine learning applications in healthcare clinical practice and research
-
11/7/2024 5:10:59 AM | Browse: 158 | Download: 582
|
| 46 |
-
Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
-
10/21/2024 7:03:25 AM | Browse: 145 | Download: 707
|
| 47 |
-
Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
-
10/14/2024 7:12:19 AM | Browse: 132 | Download: 469
|
| 48 |
-
Innovative mesenchymal stem cell treatments for fatty liver disease
-
9/24/2024 3:15:41 AM | Browse: 159 | Download: 576
|
| 49 |
-
Mechanism of mesenchymal stem cells in liver regeneration: Insights and future directions
-
9/24/2024 3:15:41 AM | Browse: 196 | Download: 607
|
| 50 |
-
Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
-
9/23/2024 10:30:40 AM | Browse: 241 | Download: 775
|
